Zobrazeno 1 - 4
of 4
pro vyhledávání: '"V A Deygin"'
Autor:
V A Nassonova, G N Pleskovskaya, S G RadenskaLopovok, Y V Muravjov, A V Novikova, I. S. Didikina, V A Deygin
Publikováno v:
Научно-практическая ревматология, Vol 41, Iss 3, Pp 24-27 (2003)
Objective. To assess efficacy of new immunoactive peptide thymodepressine (TD) selectively inhibiting T-cell immunity in rheumatic diseases Methods. Spleen, kidneys and synovial membrane morphological changes and survival were assessed in 100 MRL/1 f
Externí odkaz:
https://doaj.org/article/0d17f32cfed5449da9507961e45005ff
Autor:
T. D. Volkova, Inna V. Nesterova, N. I. Medvinskaya, Ya. V. Zaporozhskaya, I. Yu. Aleksandrova, A. N. Samokhin, D. O. Koroev, V. I. Deygin, A. V. Kamynina, Olga M. Volpina, N. V. Bobkova
Publikováno v:
Russian Journal of Bioorganic Chemistry. 41:125-132
The prion protein is considered as one of the membrane targets of the neurotoxic beta-amyloid during development of Alzheimer’s disease. We chose and synthesized peptide fragments that corresponded to the 17–33, 23–33, 95–110, and 101–115 s
Autor:
O M, Volpina, T D, Volkova, N I, Medvinskaya, A V, Kamynina, Y V, Zaporozhskaya, I J, Aleksandrova, D O, Koroev, A N, Samokhin, I V, Nesterova, V I, Deygin, N V, Bobkova
Publikováno v:
Bioorganicheskaia khimiia. 41(2)
The prion protein is considered as one of the membrane targets of neurotoxic beta-amyloid during Alzheimer's disease development. We have chosen and synthesized 17-33, 23-33, 95-110 and 101-115 prion fragments involved in beta-amyloid binding. The ef
Autor:
S G RadenskaLopovok, V A Nassonova, G N Pleskovskaya, Y V Muravjov, I. S. Didikina, V A Deygin, A V Novikova
Publikováno v:
Научно-практическая ревматология, Vol 41, Iss 3, Pp 24-27 (2003)
Objective. To assess efficacy of new immunoactive peptide thymodepressine (TD) selectively inhibiting T-cell immunity in rheumatic diseases Methods. Spleen, kidneys and synovial membrane morphological changes and survival were assessed in 100 MRL/1 f